Papel de la comorbilidad en el impacto de la sarcopenia sobre la función musculoesquelética

Carlos Luis Vela-Barba

doi:10.35663/amp.2014.312.204

Carlos Luis Vela-Barba Hospital Central de Aeronáutica. Lima, Perú

DOI: https://doi.org/10.35663/amp.2014.312.204

Abstract

Papel de la comorbilidad en el impacto de la sarcopenia sobre la función musculoesquelética

Downloads

Download data is not yet available.

Author Biography

Carlos Luis Vela-Barba, Hospital Central de Aeronáutica. Lima, Perú

Jefe del Servicio de Hospitalización de Geriatría. Hospital Central de Aeronáutica. Lima, Perú

References

Lynch GS. Sarcopenia -age-related muscle wasting and weakness. Mechanisms and treatments. Springer; 2010.

Rosenberg I. Summary comments. Am J Clin Nutr. 1989;50:1231-3.

Clark BC, Manini TM. Curr functional consequences of sarcopenia and dynapenia in the elderly. Curr Opin Clin Nutr Metab Care. 2010.;13;271-276.

Morley JE, Abbatecola AM, Argiles JM, Baracos V, Bauer J, Bhasin S. Sarcopenia with limited mobility: An international Consensus. J Am Med Dir Assoc. 2011;12:403-409.

Hicks GE, Shardell M, Alley DE, Miller RR, Bandinelli S, Guralnik J. Absolute strength and loss of strength as predictors of mobility decline in older adults: The InCHIANTI Study. J Gerontol A Biol Sci Med Sci. 2012;67(1):66-73.

Pahor M, Cesari M. Designing Phase II B Trials in Sarcopenia: The Best Target Population. J Nutr Health Aging. 2011;15(8):725-730.

Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, Newman AB, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. International Working roup on Sarcopenia. J Am Med Dir Assoc. 2011;12: 249-256.

Viswanathan A1, Rocca WA, Tzourio C. Vascular risk factors and dementia. How to move forward? Neurology. 2009;72:368-374.

Cruz-Jentoft AJ, Baeyens, JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European Consensus on Definition and Diagnosis. Age Ageing. 2010;39:412-423.

Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998;147:755.

Ferrucci L, Studenski S. Diabetes, muscles, and the myth of Ulysses' bow. Diabetes Care. 2009;32:2136-2137.

Rolland Y, van Kan GA, Gillette-Guyonnet S, Vellas B. Cachexia versus sarcopenia. Curr Op Clin Nutr Metab Care. 2011;14:15-21.

Prado CMM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, Baracos VE. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9(7):629-635.

Gosker HR, Zeegers MP, Wouters EFM, Schols AMWJ. Muscle fibre type shifting in the vastus lateralis of patients with COPD s associated with disease severity: a systematic review and metaanalysis. Thorax. 2007;62:944-949.

Kim J, Sapienza CM. Implications of expiratory muscle strength training for rehabilitation of the elderly: Tutorial. J Rehabil Res Dev. 2005;42(2):211-224.